Fractyl Health to Participate in the Upcoming December Conferences
Fractyl Health to Participate in the Upcoming December Conferences
Format: Fireside ChatBURLINGTON, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the "Company"), a metabolic therapeutics company focused on pioneering new approaches that treat root causes of obesity and Type 2 Diabetes (T2D), today announced that Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer of the Company, will present at two upcoming investor conferences.
馬薩諸塞州伯靈頓，2024年11月26日（環球新聞）-- Fractyl Health, Inc.（納斯達克：GUTS）（以下簡稱「公司」），是一家專注於開創治療肥胖和2型糖尿病（T2D）根本原因的新療法公司，今天宣佈公司的聯合創始人兼首席執行官Harith Rajagopalan萬.D., Ph.D.將參加即將舉行的兩場投資者會議。
Details of the presentations can be found below.
演講的詳細信息如下。
7th Annual Evercore ISI HealthCONx Conference
第7屆Evercore ISI HealthCONx會議
Format: Fireside Chat
形式：爐邊聊天
Date: 12/03/2024
日期：2024年12月03日
Time: 7:30 AM ET
時間：東部時間上午7:30
Piper Sandler 36th Annual Healthcare Conference
派傑投資第36屆醫療保健年會
Format: Fireside Chat
形式：爐邊聊天
Date: 12/04/2024
日期：2024年12月04日
Time: 1:30 PM ET
時間：東部時間下午1:30
Webcast replays will be accessible following the live sessions on the Events page of the Investors section on the Company's website at .
活動結束後的網絡直播回放將在公司網站投資者部分的活動頁面上提供。
About Fractyl Health
關於Fractyl Health
Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including obesity and T2D. Despite advances in treatment over the last 50 years, obesity and T2D continue to be rapidly growing drivers of morbidity and mortality in the 21st century. Fractyl Health's goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target the organ-level root causes of disease. Fractyl Health is based in Burlington, MA. For more information, visit .
Fractyl Health是一家代謝治療公司，致力於開創治療代謝疾病的新方法，包括肥胖症和2型糖尿病(T2D)。儘管在過去50年中治療取得了進展，但肥胖症和T2D依然是21世紀致病率和死亡率快速增長的主要原因。Fractyl Health的目標是將代謝疾病的治療從慢性症狀管理轉變爲可持續的疾病修飾療法，針對疾病的器官級根本原因。Fractyl Health總部位於馬薩諸塞州伯靈頓。欲了解更多信息，請訪問。
Contacts
聯繫人
Corporate Contact
Lisa Davidson, Chief Financial Officer
ir@fractyl.com, 781.902.8800
企業聯繫方式
麗莎·戴維森，首席財務官
ir@fractyl.com, 781.902.8800
Media Contact
Jessica Cotrone, Corporate Communications
jcotrone@fractyl.com, 978.760.5622
媒體聯繫人
Jessica Cotrone，企業傳播
jcotrone@fractyl.com, 978.760.5622
Investor Contact
Stephen Jasper Gilmartin Group
stephen@gilmartinir.com, 619.949.3681
投資者聯繫
斯蒂芬·賈斯珀·吉爾馬丁集團
stephen@gilmartinir.com, 619.949.3681
